Alexandria T M Lee

9PUBLICATIONS
5CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Solid tumoursGene and molecular therapyMolecular targetsOpen access
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 01, 2026
Incretin Receptor Agonist, Semaglutide, as a Treatment for Alectinib-Induced Excessive Weight Gain. A Case Report.

Alexandria T M Lee, Cathleen June Park, Zhaohui Liao Arter

|Jan 08, 2025
ALK Tyrosine Kinase Inhibitors Induced Weight Gain: More Refined Definition of Weight Gain, Glucagon-Like Peptide-1 Agonist Treatment, and Therapeutic Drug Monitoring of ALK+ Non-Small Cell Lung Cancer?

Cathleen June Park, Alexandria T M Lee, Sai-Hong Ignatius Ou

|Dec 24, 2024
Adagrasib in KRYSTAL-12 has Not Broken the KRAS G12C Enigma Code of the Unspoken 6-Month PFS Barrier in NSCLC.

Alexandria T M Lee, Misako Nagasaka

|May 29, 2024
LIBRETTO-431: Confirming the Superiority of Selpercatinib to Chemotherapy and the Lack of Efficacy of Immune Checkpoint Inhibitors in Advanced RET Fusion-Positive (RET+) NSCLC, Another Unique Never-Smoker Predominant Molecular Subtype of NSCLC.

Alexandria T M Lee, Sai-Hong Ignatius Ou

|Mar 04, 2024
Overcoming Central β-Sheet #6 (Cβ6) ALK Mutation (L1256F), TP53 Mutations and Short Forms of EML4-ALK v3/b and v5a/b Splice Variants are the Unmet Need That a Re-Imagined 5th-Generation (5G) ALK TKI Must Deliver.

Alexandria T M Lee, Sai-Hong Ignatius Ou

|Jul 13, 2023
ALESIA 5-Year Update: Alectinib at 600 mg Twice Daily Gives Lorlatinib a Run for Its Money in Asia.

Alexandria T M Lee, Saihong Ignatius Ou

Pageof 2

Frequent Collaborators

6 joint publications

Saihong Ignatius Ou

4 joint publications

Misako Nagasaka

2 joint publications

Cathleen June Park

1 joint publications

Shannon S Zhang